Letters to the Editor Open access

Invasive pulmonary aspergillosis in a COVID-19 recovered patient: unravelling an infective sequalae of the SARS-CoV-2 virus

Authors

Published
6 April 2021
Section
Letters to the Editor

Abstract

Dear Editor,

A 55-year-female, house wife, non-smoker, morbidly obese (BMI>35) with no other co-morbidities or pre-existing lung disease presented to the emergency room with complaints of highgrade fever, cough with minimal sputum, progressive breathlessness, streaky haemoptysis, and anorexia for the past 5 days. She was admitted in intensive care unit (ICU) for severe COVID-19 pneumonia three months back and had successfully recovered after 24 days of hospitalization....

Supporting Agencies

None

References

  1. Franquet T, Müller NL, Giménez A, et al. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics 2001;21:825-37. DOI: https://doi.org/10.1148/radiographics.21.4.g01jl03825
  2. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 2011;20:156-74. DOI: https://doi.org/10.1183/09059180.00001011
  3. Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med 2018;6:782-92. DOI: https://doi.org/10.1016/S2213-2600(18)30274-1
  4. Prattes J, Valentin T, Hoenigl M, et al. Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report. Med Mycol Case Rep 2020;31:2-5. DOI: https://doi.org/10.1016/j.mmcr.2020.05.001
  5. Helleberg M, Steensen M, Arendrup MC. Invasive aspergillosis in patients with severe COVID-19 pneumonia. Clin Microbiol Infect 2020;27:147-8. DOI: https://doi.org/10.1016/j.cmi.2020.07.047
  6. van Arkel ALE, Rijpstra TA, Belderbos HNA, et al. COVID-19-associated pulmonary aspergillosis. Am J Respir Crit Care Med 2020;202:132-5. DOI: https://doi.org/10.1164/rccm.202004-1038LE
  7. Rutsaert L, Steinfort N, Van Hunsel T, et al. COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care 2020;10:71. DOI: https://doi.org/10.1186/s13613-020-00686-4
  8. Arastehfar A, Carvalho A, van de Veerdonk FL, et al. COVID-19 associated pulmonary aspergillosis (CAPA) - From immunology to treatment. J Fungi (Basel) 2020;6:91. DOI: https://doi.org/10.3390/jof6020091
  9. Armstrong-James D, Youngs J, Bicanic T, et al. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Eur Respir J 2020;56:2002554. DOI: https://doi.org/10.1183/13993003.02554-2020
  10. Patterson TF, Thompson GR 3rd, Denning DW, et al. practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016;63:e1-e60. DOI: https://doi.org/10.1093/cid/ciw326

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.